Rat liver injury following normothermic ischemia is prevented by a phosphinic matrix metalloproteinase inhibitor
Open Access
- 14 November 2001
- journal article
- fj express-summaries
- Published by Wiley in The FASEB Journal
- Vol. 16 (1) , 1-24
- https://doi.org/10.1096/fj.01-0279fje
Abstract
Hepatic ischemia occurs in liver transplantation, hemodynamic or cardiogenic shock, and liver resection associated with trauma or tumor. Ischemia/reperfusion (I/R) injury results in microcirculation ...Keywords
Funding Information
- Institut National de la Santé et de la Recherche Médicale
- Université Nice Sophia Antipolis
- Fondation de France
This publication has 59 references indexed in Scilit:
- Tissue Inhibitor of Metalloproteinases–1 Promotes Liver Fibrosis Development in A Transgenic Mouse ModelHepatology, 2000
- Regulation and Significance of Hepatocyte-Derived Matrix Metalloproteinases in Liver RemodelingBiochemical and Biophysical Research Communications, 2000
- Glutathione, lactobionate, and histidine: cryptic inhibitors of matrix metalloproteinases contained in university of wisconsin and histidine/tryptophan/ketoglutarate liver preservation solutionsHepatology, 2000
- Different Bone Growth Rates Are Associated With Changes in the Expression Pattern of Types II and X Collagens and Collagenase 3 in Proximal Growth Plates of the Rat TibiaJournal of Bone and Mineral Research, 2000
- Expression patterns of matrix metalloproteinases and their inhibitors in parenchymal and non-parenchymal cells of rat liver: regulation by TNF-α and TGF-β1Journal of Hepatology, 1999
- Improvement of Normothermic Rat Liver Ischemia/Reperfusion by Muramyl DipeptideJournal of Surgical Research, 1998
- Differential Expression and Origin of Membrane-Type 1 and 2 Matrix Metalloproteinases (MT-MMPs) in Association with MMP2 Activation in Injured Human LiversThe American Journal of Pathology, 1998
- Matrix Metalloproteinase Expression Increases After Cerebral Focal Ischemia in RatsStroke, 1998
- Dual expression of matrix metalloproteinase-2 and membrane-type 1-matrix metalloproteinase in fibrotic human liversHepatology, 1997
- FK 506 pre-treatment is associated with reduced levels of tumor necrosis factor and interleukin 6 following hepatic ischemia/reperfusionJournal of Hepatology, 1993